Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,516.27 98.74 0.68%
TOPIX 1,173.37 6.78 0.58%
HANG SENG 22,760.24 64.23 0.28%

The Zacks Analyst Blog Highlights:EdisonInternational, Dominion Resources, Shire, Johnson & Johnson and Novartis



  The Zacks Analyst Blog Highlights:EdisonInternational, Dominion Resources,
                    Shire, Johnson & Johnson and Novartis

PR Newswire

CHICAGO, Dec. 24, 2012

CHICAGO, Dec. 24, 2012 /PRNewswire/ -- Zacks.com announces the list of stocks
featured in the Analyst Blog. Every day the Zacks Equity Research analysts
discuss the latest news and events impacting stocks and the financial markets.
Stocks recently featured in the blog include Edison International (NYSE:EIX),
Dominion Resources Inc. (NYSE:D), Shire plc (Nasdaq:SHPG), Johnson & Johnson
(NYSE:JNJ) and Novartis (NYSE:NVS).

(Logo:  http://photos.prnewswire.com/prnh/20101027/ZIRLOGO)

Get the most recent insight from Zacks Equity Research with the free Profit
from the Pros newsletter: http://at.zacks.com/?id=5513

Here are highlights from Friday's Analyst Blog:

Edison Int'l Hikes Dividend

EdisonInternational (NYSE:EIX) has increased its quarterly dividend by 3.85%,
bringing the annualized dividend to $1.35 per share from the previous payout
of $1.30 per share.

The quarterly dividend, after the hike, will come to 33.75 cents per share, up
from the prior payment of 32.50 cents per share. The first increased dividend
will be paid on January 31, 2013 to shareholders of record on December 31,
2012.

This marks the ninth consecutive annual increase of Edison's common stock
dividend. Last year in December 2011, the company had increased the annual
dividend by 1.56% to $1.30 from $1.28.

The company targets a dividend payout ratio of 45% to 55% of the earnings of
Southern California Edison. This increase of 3.85% would prove to be the first
step in achieving this target. Further, this target payout ratio can be
achieved with the company's attempts of moderating its capital expenditure
levels at Southern California Edison.

The continuous increase in dividend reflects the company's focus on balancing
dividend growth and increase in shareholder's value. Moreover, the company
seems to be making the best use of its liquidity position with a cash balance
of $1.08 billion.

In September this year, the company announced that as a part of Edison
SmartConnect program, it plans to install smart electric meters in the San
Joaquin Valley. Edison SmartConnect is a $1.6 billion program authorized by
the California Public Utilities Commission. Edison SmartConnect meters are
digital, safe and mutual communicating devices. The company will replace the
traditional mechanical meters, which would result in the transition of
electric system into a smart grid.

The company expects its sustained energy conservation to reduce greenhouse gas
emissions and smog forming pollutants by an estimated 365,000 metric tons per
year, which is equivalent of removing 79,000 cars from the road. These meters
will allow the residential and small business customers to benefit from new
energy and cost-saving programs and services in the near term.

With its strong portfolio of regulated utility assets and well-managed
merchant energy operations, Edison International presents a lower risk profile
compared to its utility-only peers. Going forward, key growth drivers for the
company are consistent performance of its stable utility operations,
California's supportive regulatory environment, steep growth in the rate base,
incremental dividend, and ongoing alternative energy projects, which is in
line with the renewable energy mandate.

However, we remain concerned due to the tepid economy, volatile gas prices and
the pending regulatory approval for recovery of capital expansion costs. The
company presently retains a short-term Zacks #3 Rank (Hold) that corresponds
with our long-term Neutral recommendation on the stock.

Another power provider company Dominion Resources Inc. (NYSE:D) also recently
hiked its dividend rate to $2.25 per share for 2013, reflecting a 6.6%
increase from $2.11 per share in 2012.

California-based Edison International is a utility holding company operating
through its principal subsidiaries: Southern California Edison Company, Edison
Mission Energy, and Edison Capital.

Encouraging News for Shire

Shire plc (Nasdaq:SHPG) recently received some encouraging news from Europe
regarding its attention deficit/hyperactivity disorder (ADHD) drug, Vyvanse
(proposed trade name in Europe: Elvanse). The Ireland based company announced
a favorable outcome from the European Decentralised Procedure (DCP) regarding
its ADHD drug, which will be marketed as Tyvense in Ireland.

We note that the drug is marketed in the US and Canada under the trade name
Vyvanse, for treating ADHD in children, adolescents and adults. Moreover, the
drug is marketed in Brazil under the trade name Venvanse for treating children
in the age-group of 6-12 years suffering from ADHD.

Elvanse will be marketed in Europe (on approval) for treating children aged 6
years and above following inadequate response to methylphenidate therapy. We
note that the UK Medicines and Healthcare products Regulatory Agency (MHRA)
was the reference member state on behalf of seven other European nations
(Denmark, Finland, Germany, Ireland, Norway, Spain and Sweden), which
participated in the process. The countries have agreed regarding labeling of
the drug. The approval to market the drug in the individual European countries
will be issued by the respective regulatory authorities.  The process is
expected to consume one to three months more. The MHRA accepted the ADHD drug
for review in January 2012.

We note that Vyvanse is one of the most widely prescribed ADHD therapies in
the US. Approval in additional markets would further boost the sales potential
of the drug. The ADHD market offers significant commercial potential. Apart
from Shire, the ADHD market boasts of players, such as Johnson & Johnson
(NYSE:JNJ) and Novartis (NYSE:NVS).

We currently have a Neutral recommendation on Shire. It carries a Zacks #3
Rank (Hold rating) in the short run.

Want more from Zacks Equity Research? Subscribe to the free Profit from the
Pros newsletter: http://at.zacks.com/?id=5515.

About Zacks Equity Research

Zacks Equity Research provides the best of quantitative and qualitative
analysis to help investors know what stocks to buy and which to sell for the
long-term.

Continuous coverage is provided for a universe of 1,150 publicly traded
stocks. Our analysts are organized by industry which gives them keen insights
to developments that affect company profits and stock performance.
Recommendations and target prices are six-month time horizons.

Zacks "Profit from the Pros" e-mail newsletter provides highlights of the
latest analysis from Zacks Equity Research. Subscribe to this free newsletter
today: http://at.zacks.com/?id=5517

About Zacks

Zacks.com is a property of Zacks Investment Research, Inc., which was formed
in 1978 by Leon Zacks. As a PhD from MIT Len knew he could find patterns in
stock market data that would lead to superior investment results. Amongst his
many accomplishments was the formation of his proprietary stock picking
system; the Zacks Rank, which continues to outperform the market by nearly a 3
to 1 margin. The best way to unlock the profitable stock recommendations and
market insights of Zacks Investment Research is through our free daily email
newsletter; Profit from the Pros. In short, it's your steady flow of
Profitable ideas GUARANTEED to be worth your time! Register for your free
subscription to Profit from the Pros at http://at.zacks.com/?id=5518.

Visit http://www.zacks.com/performance for information about the performance
numbers displayed in this press release.

Follow us on Twitter: http://twitter.com/zacksresearch

Join us on Facebook:
http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts

Disclaimer: Past performance does not guarantee future results. Investors
should always research companies and securities before making any investments.
Nothing herein should be construed as an offer or solicitation to buy or sell
any security.

Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com 
http://www.zacks.com

SOURCE Zacks Investment Research, Inc.

Website: http://www.zacks.com
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement